Given the hypermethylated phenotype of IDH-mutant astrocytomas, MGMT promoter hypermethylation is prevalent in IDH-mutant astrocytomas; however, it is said to have prognostic, as opposed to predictive, value [14,15]. Here, MGMT is linked to astrocytoma (excluding glioblastoma).